Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MATTHEW P MARDINEY

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1144271073
CMS profile
97276
Location
BEL AIR, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,490.40

157 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,405.41 156
Education $84.99 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MATTHEW P MARDINEY

NPI 1144271073 · CMS profile ID 97276

Allopathic & Osteopathic Physicians / Allergy & Immunology

BEL AIR, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1144271073?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MATTHEW P MARDINEY, NPI 1144271073, CMS profile ID 97276. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1144271073?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MATTHEW P MARDINEY, NPI 1144271073, CMS profile ID 97276. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1144271073?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MATTHEW P MARDINEY, NPI 1144271073, CMS profile ID 97276, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1144271073?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

157 matching records · $3,490.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 157 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 157.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $22.4405/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335040 CMS
PFIZER INC. $20.0205/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230105471 CMS
GlaxoSmithKline, LLC. $10.2505/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190427218 CMS
Lilly USA, LLC $76.8005/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186815123 CMS
ABBVIE INC. $5.0705/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017568 CMS
ABBVIE INC. $22.4105/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017570 CMS
Regeneron Healthcare Solutions, Inc. $29.6805/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212983110 CMS
AstraZeneca Pharmaceuticals LP $19.8805/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206184410 CMS
AstraZeneca Pharmaceuticals LP $16.8105/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206434299 CMS
Novartis Pharmaceuticals Corporation $17.7405/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200650746 CMS
GENZYME CORPORATION $6.0305/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335038 CMS
Arcutis Biotherapeutics, Inc. $14.0105/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252359897 CMS
Genentech USA, Inc. $17.6304/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211547075 CMS
GENZYME CORPORATION $22.4404/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335026 CMS
Regeneron Healthcare Solutions, Inc. $22.1104/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212983108 CMS
Novartis Pharmaceuticals Corporation $13.5804/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200650742 CMS
GlaxoSmithKline, LLC. $12.9304/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190854518 CMS
SANOFI-AVENTIS U.S. LLC $84.9904/18/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1233335028 CMS
AstraZeneca Pharmaceuticals LP $22.7104/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206342842 CMS
Amgen Inc. $17.8404/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228469462 CMS
GlaxoSmithKline, LLC. $29.7504/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190411313 CMS
Galderma Laboratories, L.P. $16.9804/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234675779 CMS
ABBVIE INC. $1.7703/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017566 CMS
GENZYME CORPORATION $19.9203/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335022 CMS
GENZYME CORPORATION $14.8803/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335120 CMS
ABBVIE INC. $14.2903/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017564 CMS
AstraZeneca Pharmaceuticals LP $21.6203/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206681272 CMS
Optinose US, Inc. $24.9703/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163254710 CMS
ABBVIE INC. $23.5203/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017562 CMS
PFIZER INC. $17.9903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231533849 CMS
PFIZER INC. $20.0703/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231362303 CMS
Genentech USA, Inc. $16.1403/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211547071 CMS
AstraZeneca Pharmaceuticals LP $30.5403/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206738916 CMS
Lilly USA, LLC $15.1003/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186827440 CMS
GENZYME CORPORATION $19.6102/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335016 CMS
Organon LLC $15.0902/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237660524 CMS
Lilly USA, LLC $17.1302/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186777665 CMS
ABBVIE INC. $20.6102/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017560 CMS
Optinose US, Inc. $23.4602/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163254708 CMS
ABBVIE INC. $28.2602/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017558 CMS
GENZYME CORPORATION $20.6602/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233335006 CMS
Regeneron Healthcare Solutions, Inc. $26.6102/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212983106 CMS
PFIZER INC. $13.2002/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230031781 CMS
ABBVIE INC. $13.3201/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203017556 CMS
AstraZeneca Pharmaceuticals LP $10.8501/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206555431 CMS
Amgen Inc. $23.0601/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228469460 CMS
Novartis Pharmaceuticals Corporation $19.5701/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200650738 CMS
Organon LLC $19.3601/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237660526 CMS
PFIZER INC. $19.6001/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231117354 CMS
CSL Behring $31.9001/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232349992 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,178.63 138
PY2020 $2,227.83 127
PY2021 $2,780.34 163
PY2022 $3,660.77 188
PY2023 $3,550.11 170
PY2024 $3,407.02 163
PY2025 $3,490.40 157

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $80,299.52 20
PY2024 Principal investigator $119,903.81 23
PY2023 Principal investigator $102,715.27 17
PY2022 Principal investigator $72,156.07 10
PY2021 Principal investigator $27,803.05 6
PY2020 Principal investigator $99,594.29 26
PY2019 Principal investigator $119,148.78 36

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $250.00 11/12/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184260251
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $5,000.00 11/12/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184260253
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $762.00 11/12/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184260255
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $133.00 11/12/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184260257
Principal investigator 1 Vanda Pharmaceuticals Inc. $3,700.00 10/22/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232946646
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,300.00 10/22/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232946650
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $107.94 10/21/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051639
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $71.96 10/08/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051637
Principal investigator 1 SANOFI US SERVICES INC. $4,000.00 09/22/2025 Non-covered Recipient Entity
Continental Clinical Solutions, Llc
A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis Who Participated in KY1005-CT05 (DRI17366) No dispute reported 06/30/2026 1226108783
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $4,000.00 08/06/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051485
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $2,000.00 08/06/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051487
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $5,000.00 08/06/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051489
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $10,000.00 08/06/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051491
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,900.00 07/03/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945681
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $179.90 06/18/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244051635
Principal investigator 1 Vanda Pharmaceuticals Inc. $5,800.00 04/23/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945286
Principal investigator 1 Vanda Pharmaceuticals Inc. $800.00 02/25/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944924
Principal investigator 1 Amgen Inc. $21,794.72 01/27/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS, LLC
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246640511
Principal investigator 1 Vanda Pharmaceuticals Inc. $8,600.00 01/22/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944633
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,900.00 01/22/2025 Non-covered Recipient Entity
CONTINENTAL CLINICAL SOLUTIONS LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944637